(Q57739418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

meta-analysis

0 references

title

Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

M Zivkov

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K C Roes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A G Pols

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

European Neuropsychopharmacology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

115-124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Fluoxetine potentiation by buspirone: three case histories

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Quantitative rating of depressive states

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

1 reference

7 January 2021

Symptoms as predictors of response in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

A double-blind placebo-controlled study of Org 3770 in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

A study comparing paroxetine placebo and imipramine in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

1 reference

7 January 2021

Plasma levels and antidepressive effect of imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Comparative efficacy of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

The timing, specificity and clinical prediction of tricyclic drug effects in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Fluoxetine in patients with major depressive disorder--a responder analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

The advantages of paroxetine in different subgroups of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

The efficacy of fluvoxamine in patients with severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Severity of depression and response to fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

An overview of statistical issues and methods of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

Mirtazapine is more effective than trazodone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

A general parametric approach to the meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900394-X

7 January 2021

10.1016/S0924-977X(96)00394-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9169299%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference